RxDoctor Payments Data

Natalia Saprykina, MD

Obstetrics & Gynecology · Anchorage, AKNPI 1720184369

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,585 of the $5,887 with a category attached, or 60.9%. 16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.9% of the total. Reporting peaked in 2023 at $3,219 and has fallen 95.2% since, to $153 in 2025. Among obstetrics & gynecology clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,887in general payments, 2019–2025

Across 67 payments — averaging $87.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$3K
  • Coloplast$710
  • Medline Industries LP$708
  • Astellas Pharma US Inc$515
  • Hologic Sales And Service, LLC$259
  • AbbVie$147
  • plus $608 from 10 others

What the payments were for

  • Travel & lodging$3,58561%
  • Food & beverage$1,91633%
  • Education$3746%
  • Gifts$110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,887 in reported general payments places this provider in the 90th percentile of 97 obstetrics & gynecology providers in Alaska.

See all obstetrics & gynecology providers in Alaska

Medicare billing

Part B allowed, 2024
$23,601
Medicare patients
58
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol17$1,533

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →